Utah Medical Products, Inc.

Utah Medical Products, Inc. (UTMD) Market Cap

Utah Medical Products, Inc. has a market capitalization of $226.3M.

Financials based on reported quarter end 2025-12-31

Price: $70.65

โ–ฒ 1.10 (1.58%)

Market Cap: 226.34M

NASDAQ ยท time unavailable

CEO: Kevin L. Cornwell

Sector: Healthcare

Industry: Medical - Instruments & Supplies

IPO Date: 1999-03-08

Website: https://www.utahmed.com

Utah Medical Products, Inc. (UTMD) - Company Information

Market Cap: 226.34M ยท Sector: Healthcare

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Analyst Sentiment

50%
Hold

Based on 0 ratings

Consensus Price Target

No data available

Price & Moving Averages

Loading chart...

Fundamentals Overview

Loading fundamentals overview...

๐Ÿ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"UTMD reported revenue of $9.044M and a net income of $2.565M, translating to an earnings per share (EPS) of $0.77, indicating a profitable operation despite modest revenue. The company holds total assets of $122.542M against total liabilities of only $3.274M, leading to a robust equity position of $119.268M and negative net debt of -$85.531M, reflecting strong financial health. The operating cash flow stands at $3.878M, and free cash flow is a solid $3.851M, showcasing effective cash generation capabilities. Dividends paid amounted to $0.988M in the recent period, aligning with a commitment to returning value to shareholders. With a market price of $63.8, UTMD has experienced a 1-year price appreciation of 11.85%, though it remains below the 20% threshold for higher assessment of shareholder returns. Overall, while the company shows strong fundamentals and profitability, its revenue growth and shareholder return metrics are notable areas for attention."

Revenue Growth

Fair

Revenue growth is present, but minimal compared to overall potential.

Profitability

Good

Strong net income relative to revenue indicates solid profitability.

Cash Flow Quality

Good

Consistent operating and free cash flow shows healthy liquidity position.

Leverage & Balance Sheet

Strong

Very low liabilities relative to assets and negative net debt indicate a strong balance sheet.

Shareholder Returns

Neutral

While dividends are present, price appreciation hasnโ€™t exceeded 20%.

Analyst Sentiment & Valuation

Neutral

No current price targets but price stability reflects cautious sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
๐Ÿ“

SEC Filings (UTMD)

ยฉ 2026 Stock Market Info โ€” Utah Medical Products, Inc. (UTMD) Financial Profile